Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Accumulated Expenses (2020 - 2024)

Neuroone Medical Technologies' Other Accumulated Expenses history spans 5 years, with the latest figure at $258244.0 for Q4 2024.

  • For Q4 2024, Other Accumulated Expenses rose 2482.44% year-over-year to $258244.0; the TTM value through Dec 2024 reached $258244.0, up 2482.44%, while the annual FY2024 figure was $59950.0, N/A changed from the prior year.
  • Other Accumulated Expenses reached $258244.0 in Q4 2024 per NMTC's latest filing, up from $59950.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $258244.0 in Q4 2024 to a low of $10000.0 in Q4 2023.
  • Average Other Accumulated Expenses over 5 years is $92432.7, with a median of $59950.0 recorded in 2024.
  • Peak YoY movement for Other Accumulated Expenses: crashed 83.6% in 2022, then skyrocketed 2482.44% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $218125.0 in 2020, then plummeted by 61.88% to $83152.0 in 2021, then plummeted by 73.54% to $22001.0 in 2022, then crashed by 54.55% to $10000.0 in 2023, then surged by 2482.44% to $258244.0 in 2024.
  • Per Business Quant, the three most recent readings for NMTC's Other Accumulated Expenses are $258244.0 (Q4 2024), $59950.0 (Q3 2024), and $17007.0 (Q1 2024).